Literature DB >> 2659099

Factor concentrates for treatment of hemophilia: which one to choose?

D B Brettler1, P H Levine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2659099

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

Review 1.  Haematology.

Authors:  N T O'Connor
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

2.  Preparation of lyophilized heat-treated cryoprecipitates from a small pool of plasma obtained by apheresis.

Authors:  D P Allersma; E Roeffen; J A Van der Does; E Briët
Journal:  Pharm Weekbl Sci       Date:  1991-02-22

Review 3.  Cardiopulmonary bypass in patients with pre-existing coagulopathy.

Authors:  William DeBois; Junli Liu; Leonard Lee; Leonard Girardi; Wilson Ko; Anthony Tortolani; Karl Krieger; O Wayne Isom
Journal:  J Extra Corpor Technol       Date:  2005-03

4.  HIV infection in haemophilia--a European cohort.

Authors:  A Aronstam; B Congard; D I Evans; C F Gazengel; U Herberg; F G Hill; P M Jones; R Ljung; E P Mauser-Bunschoten; E Scheibel
Journal:  Arch Dis Child       Date:  1993-04       Impact factor: 3.791

5.  Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.

Authors:  V J Dwarki; P Belloni; T Nijjar; J Smith; L Couto; M Rabier; S Clift; A Berns; L K Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

Review 6.  Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV.

Authors:  P H Duesberg
Journal:  Genetica       Date:  1995       Impact factor: 1.082
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.